Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 617-441-5 | CAS number: 83121-18-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to birds
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Reliable information on the short-term (acute) toxicity of the test item to birds is available. No information on the long-term (chronic) toxicity to birds is available.
Two valid GLP-compliant guideline studies on the acute oral toxicity of the test item to birds are available and summarized below. Both studies were submitted in the EU and are summarized in the original Draft Assessment Report (DAR) for teflubenzuron in accordance to the Council Directive 91/414/EEC (2007) and the Addendum to the DAR (November 2002).
Supporting information
Huntington Research Centre (1987): The Acute Oral Toxicity (LD50) of CME 134 to the Mallard Duck. Unpublished report, report No. FCC 99/851578, according to Draft Assessment Report (2007) according to Council Directive 91/414/EEC, crossreference MCA 8.1.1/01
An acute oral toxicity test according to Guideline US EPA/FIFRA No. 71-1 (1983) was carried out to investigate the acute toxic effects of teflubenzuron (CME 134) in the Mallard duck (Anas platyrhynchos).
40 male and 40 female birds (Anas platyrhynchos) with an age over 16 weeks and with a bodyweight of 840–1250 g were obtained. 24 male and 24 female birds were used in the study (2 for the range-finding test, 40 in the main study, 6 for use as possible replacements). The birds were housed in pens of galvanised steel measuring 1.5 x 1.2 m with wire mesh floors. Temperatures and relative humidity were recorded daily throughout the study. The photoperiod was 7/17 hours light/dark, ventilation fans were adjusted, as necessary. The birds were offered a standard diet in pellet form, which was known to contain no antibiotics or growth promoters. Water was available all the time and feed was offered ad libitum (except an overnight starvation period prior to dosing). The birds could be identified by numbered metal wing tags. The test compound was administered in suspension in corn oil. The concentrations were calculated to give a dose volume of 5 mL suspension/kg body weight at all dose levels. Single doses were given by oral gavage on Day 0.
The duration of the study was 28 days (14 days pre-treatment period and 14 days post-treatment period). The bird’s health and mortalities were observed daily. Body weights were recorded on days -14, -7, 0 (immediately prior to dosing), 7 and 14. The group mean feed consumptions were recorded weekly over the period’s days -14 to -8, -7 to 0, 0 to 7 and 8 to 14. Birds that died during the study and all birds from the high dose level group at test termination were examined for gross pathological changes.
The mean maximum temperature was 17°C (15–20 °C), the mean minimum temperature was 13 °C (10–17 °C) and the average relative humidity was 79 % (70–92 %). No signs of toxicity were observed and all birds remained in good health throughout the study. Since there were no mortalities following dosing, it was not possible to determine an LD50 value, which must be in excess of 2000 mg a.s./kg bw. Between days –14 and 0, birds in all groups tended to decrease in weight. Following dosing, bodyweight was very variable, but overall, weight increases over days 0–14.There was no evidence of any treatment-related effect. Feed consumption data were variable but were considered to be within normal limits in all groups. With exception of the bird, which was sacrificed on day –7, no abnormalities were detected in any of the birds examined.
There was no evidence of any treatment related effects of the test item on health, body weight and feed consumption of mallard duck at any of the dose levels up to 2000 mg a.s./kg body weight. Therefore, a LD50 could not be calculated; this value is greater than 2000 mg a.s./kg body weight, which was the highest dosage level tested.
Wildlife International (1984): An Acute Oral Toxicity Study in the Bobwhite with CME-134. Unpublished report, report No. 146-106, according to Draft Assessment Report according to Council Directive 91/414/EEC, crossreference MCA 8.1.1/02
An acute oral toxicity test according to Guideline US EPA/FIFRA No. 71-1 (1982) was carried out to investigate the acute toxic effects of teflubenzuron (CME 134) in the bobwhite quail (Colinus virginianus). Apparently healthy, pen-reared, mature bobwhite quail, approximately five months old, were examined for physical injury and acclimated for at least 14 days. Groups of 10 bobwhite quail (5 male and 5 female) were distributed by random draw to each of the 5 treatment groups and the control group. 15 hours prior to dosing, feeding was stopped. Nominal dosages used in this study were 292, 486, 810, 1350 und 2250 mg a.s./kg body weight. The test substance was dispersed in corn oil and intubated into the crop via a stainless steel catheter. Each bird was weighed and dosed on the basis of mg a.s./kg body weight. The control birds received corn oil only. The concentration of test substance was adjusted to receive a constant volume to body weight dose. Feed (diet) and water were available ad libitum following dosage. The birds were housed indoors by treatment in modified Georgia Quail Farm Breeder units. Each pen measured 78 x 51 x 23 cm. The average temperature for the study was 25 ± 2 °C with an average relative humidity of 74 %. The photoperiod was 8/16 hours light/dark. All birds were observed daily and a record was maintained of all mortalities and/or signs of toxicity and abnormal behaviour. The LD50 value was determined by inspection. Body weights were recorded by groups on days 0, 3, 7 and 14. Feed consumption was measured for days 0–3, 4–7 and 8–14. Feed consumption was measured accurately, but is presented as an estimate due to the unavoidable wastage by the birds.
There were no mortalities, signs of toxicity or abnormal behaviour throughout the test. All birds were normal in appearance and behaviour throughout the test. There was no effect on body weight or feed consumption at any dosage tested. There was no evidence of any treatment related effects by the test item on health, body weight and feed consumption of bobwhite quail at any of the dose levels up to 2250 mg a.s./kg body weight. Therefore, a LD50 could not be calculated; this value was greater than 2250 mg a.s./kg body weight, which was the highest dosage tested.
Conclusion
In an avian acute oral toxicity test with Anas platyrhynchos according to Guideline US EPA/FIFRA No. 71-1 (1983) the 14-day LD50 of the test item was determined to be > 2000 mg a.s./kg bw. In a second avian acute oral toxicity test with Colinus virginianus according to Guideline US EPA/FIFRA No. 71-1 (1982) the 14-day LD50 of the test item was determined to be > 2250 mg a.s./kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.